Gyon Technologies Capital Management, LP - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gyon Technologies Capital Management, LP ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$38,000
-81.6%
20,570
-50.8%
0.03%
-62.0%
Q4 2020$206,00041,8010.07%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 48,819$36,0000.01%
Quantamental Technologies LLC 11,352$9,0000.00%
Virtu Financial LLC 19,664$15,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 45,000$33,0000.00%
Tower Research Capital LLC (TRC) 47,362$36,0000.00%
Sugarloaf Wealth Management, LLC 5,000$4,0000.00%
MORGAN STANLEY 351,836$264,0000.00%
BlackRock Inc. 186,779$140,0000.00%
Bank of New York Mellon Corp 16,643$12,0000.00%
Blackstone Inc. 16,590$12,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders